Li, Q., Wu, T., Ma, X., Jing, L., Han, L., & Guo, H. (2018). Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Ther Clin Risk Manag.
Chicago-стиль цитированияLi, Qing, Tao Wu, Xiao-An Ma, Li Jing, Li-Li Han, and Hui Guo. "Prognostic Role of ABO Blood Group in Patients With Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization." Ther Clin Risk Manag 2018.
MLA-цитированиеLi, Qing, et al. "Prognostic Role of ABO Blood Group in Patients With Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization." Ther Clin Risk Manag 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.